PRAX: Praxis Precision Medicines, Inc. Company Short-Term Debt
This price chart for Praxis Precision Medicines (PRAX) reflects the performance of a company developing targeted epilepsy treatments based on genetic analysis. The current metric is 0.00. The production cycle relies on US laboratories and high-tech platforms for personalized therapy. Strict FDA requirements and patent protection for unique small molecules ensure the exclusivity of the market niche, blocking the entry of other players.
Summary analytical data breakdowns for Praxis Corp (PRAX)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity details:
Total Debt to Capital Praxis Precision Medicines|PRAX - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Praxis Precision Medicines|PRAX - Company Aggregate Debt|Debts to Book Capitalization Praxis Precision Medicines, Inc.|PRAX - Long-Term Debt Volume|Company Short-Term Debt Praxis Precision Medicines|Quick Liquidity Indicator praxismedicines.com
- earnings and multiples data:
Fundamental valuation:Praxis Precision Medicines, Inc. (PRAX)
Fundamental asset selection is based on the analysis of liquidity and debt load. This indicator measures the volume of obligations maturing within one year, determining the business's ability to service current loans. For Praxis Precision Medicines (PRAX), this is critical when financing the robotization of electrophysiological screening. Optimizing laboratory automation costs directly impacts the organization's short-term debt. This chart reflects the balance between technological expansion and financial stability.
Competitors of Praxis Precision Medicines
BIIB - Company Short-Term Debt|Company Short-Term Loans and Borrowings NBIX (Neurocrine)|Regencell (RGC) - Company Short-Term Debt|Short-Term Debt Axsome Corp (AXSM)|Company Short-Term Debt ACADIA Pharmaceuticals|xenon-pharma.com - Current Liabilities|Company Short-Term Debt Viking Therapeutics, Inc. (VKTX)|SUPN (Supernus Pharmaceuticals, Inc.) - Company Short-Term Loans and Borrowings|Company Short-Term Debts CPRX (Catalyst Pharmaceuticals Inc)|Company Short-Term Debts Denali Corp DNLI|HRMY: Company Current Liabilities|BHVN (biohavenpharma.com) - Company Short-Term Indebtedness|AMLX: Company Short-Term Debts|TRVI - Short-Term Debt Volume|Company Short-Term Debt Anavex Corp|CeriBell EEG (CBLL) - Short-Term Debt Volume|Company Current Liabilities PRTA (Prothena)|ALEC (alector.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debt Annexon ANNX|OMER (Omeros Corp) - Current Liabilities|NGNE - Company Short-Term Debt|Company Short-Term Loans and Borrowings ACIU (AC Immune Inc)|VYGR: Company Short-Term Debts|Short-Term Debt neumoratx.com (NMRA)|SCLX (Scilex) - Company Short-Term Debts|Company Current Liabilities Tevogen Bio Holdings Inc. (TVGN)|Company Short-Term Debts ACOG|Short-Term Debt Volume cogrx.com|Company Short-Term Debt Inhibikase Therapeutics IKT|Short-Term Debt Volume cassavasciences.com (SAVA)|Assertio Therapeutics - Company Short-Term Debts|Short-Term Debt Volume Coya Therapeutics, Inc. COYA|vistagen.com (VTGN) - Company Short-Term Debt|Short-Term Debt Ovid Therapeutics (OVID)|Company Short-Term Debt Acumen Pharmaceuticals|Company Short-Term Indebtedness CRVO (cervomed.com)|Company Current Liabilities ATHE (Alterity Therapeutics)|CLNN (clene.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debt PepGen PEPG|JUNS - Company Current Liabilities|Relmada Therapeutics - Company Short-Term Debts|Short-Term Debt annovisbio.com|GRCE: Company Short-Term Debts|Company Short-Term Indebtedness AIFF|KLTO (ANEW Medical) - Company Short-Term Debts|NeuroSense Therapeutics, Ltd. (NRSN) - Short-Term Debt Volume|Company Short-Term Debts RVPH|Company Current Liabilities metaviatx.com MTVA|Company Short-Term Debts NRXS (NeurAxis)|Short-Term Debt Volume Helius Medical Technologies, Inc. (HSDT)|PASG - Company Short-Term Debt|NEUP (Neuphoria Therapeutics Inc.) - Company Short-Term Indebtedness|NERV: Company Short-Term Debts|Short-Term Debt athira.com (ATHA)|Company Short-Term Debt Addex Therapeutics Ltd|Alzamend (ALZN) - Short-Term Debt Volume|Company Short-Term Debt Cyclerion Therapeutics (CYCN)|PTIX: Current Liabilities|Company Short-Term Debt Pasithea Therapeutics Corp. KTTA|Company Short-Term Loans and Borrowings CRGT|Avenue Therapeutics, Inc. - Company Short-Term Debts|BCLI - Company Short-Term Debts|CARA (Cara Therapeutics, Inc) - Company Current Liabilities|Company Short-Term Indebtedness CHRO|Company Short-Term Debt Eliem Therapeutics, Inc.|Company Short-Term Indebtedness ITCI (Intra-Cellular)|Company Short-Term Debts LBPH|MRNS - Short-Term Debt|NKGen - Company Current Liabilities|Company Short-Term Debts NeuroBo Pharma NRBO|SAGE - Company Short-Term Debt|Company Short-Term Loans and Borrowings SNPX (synaptogen.com)|Trevena (TRVN) - Company Short-Term Debt|Short-Term Debt Vigil Neuroscience, Inc. (VIGL)|Company Short-Term Debt Anew Medical, Inc.|Cerevel Corp - Current Liabilities